European Archives - Page 539 of 1109 - European Medical Journal

Do Frozen Embryo Transfers Increase Blood Pressure Risks?

RECENT evidence has emerged from a large cohort study of the national in vitro fertilisation (IVF) registry of France, suggesting a link…

Defining Placental Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Infection with SARS-CoV-2 during pregnancy has currently been associated with several complications, including pre-eclampsia and preterm…

Keren Leshem on running a women's health business

Keren Leshem, Chief Executive Officer, OCON Healthcare, discusses how she transformed the women’s health company’s business strategy.

EMJ Podcast: Ticked Off

This week, Jonathan is discussing ticks and Lyme’s disease, explaining the history, causes, diagnosis, and prognosis of the condition. He also explores other various kinds of ticks, as well as the diseases and syndromes they can cause, and provides advice on what to do if you do get bitten.

How to avoid alienation during digital upskilling

To do well at digital transformation, pharma leaders must balance skills development with maintaining employee morale.

Melinta Therapeutics’s Christine Miller on being fuelled by purpose

Christine Miller is the President, Chief Executive Officer, and member of the board, Melinta Therapeutics, speaks to us about her path into the pharmaceutical industry, her mission to end antimicrobial resistance, and how to be an effective leader in pharma today

Navigating launch challenges for an improved patient journey

Amidst an ever-changing launch landscape, the COVID-19 pandemic has entirely disrupted the pharmaceutical industry, encouraging adaptation for success. By understanding the transformed patient journey, leveraging digital campaigns, and innovating in healthcare marketing strategies, how can pharma find new avenues for launch success?

A joint mission for social justice

Social justice is a rising priority for all industries, but particularly for the pharmaceutical sector in the wake of COVID-19 and the social inequities it unveiled. We look at how the industry is increasingly working alongside the world’s top advertising agencies to promote growth from good in their activities.

How can medical affairs lead the way in neurology?

Neurological conditions are complex and require a high level of expertise and sensitivity, making them an juicy area for medical affairs teams. How do the challenges shape the MA role in this space and how is the landscape evolving?

A breakdown of pharma's reputation

This infographic tracks the evolution of the industry’s reputation by breaking down the perspectives of individual countries and generations, while also examining the impact of the COVID-19 pandemic on public outlook.